GEODON

LOE Approaching

ziprasidone hydrochloride

NDAORALSUSPENSION
Approved
Mar 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
8

Clinical Trials (5)

NCT00472641Phase 4Completed

Geodon in Weight Loss Study for Bipolar Disorders

Started Jan 2007
25 enrolled
Bipolar Disorder
NCT00490542Phase 2Completed

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

Started Dec 2006
73 enrolled
Bipolar DisorderBipolar DepressionDepression
NCT00282464Phase 3Completed

A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.

Started Feb 2006
392 enrolled
Bipolar Disorder
NCT00141271Phase 3Completed

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

Started Jul 2005
536 enrolled
Bipolar Disorder
NCT00237666Phase 4Completed

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Started Feb 2005
30 enrolled
Bipolar II DisorderMajor Depressive Episode